<p>儘管基準指數開盤走低，但在整個交易過程中表現不佳，最終收盤下跌。</p>
<p>印度股市基準指數，Sensex 和 Nifty50，週二以負面偏向平盤收盤，儘管公營銀行、金屬和汽車板塊強勁買入，但 IT、快速消費品、房地產和製藥股的拋售抵消了這些買入。</p>
<p>在收盤時，BSE Sensex 下跌了 20 點。</p>
<p>與此同時，NSE Nifty 下跌了 3 點。</p>
<p>塔塔鋼鐵、馬恆達和巴賈傑金融是今天的主要漲幅股。</p>
<p>而 Infosys、Eternal 和 HCL Tech 則是今天的主要跌幅股。</p>
<p>GIFT Nifty 在撰寫時交易於 26,112，上漲 146 點。</p>
<p>BSE 中型股指數下跌 0.1%，BSE 小型股指數下跌 0.2%。</p>
<p>行業指數今天表現混合，醫療保健和房地產板塊的股票面臨拋售壓力。與此同時，金屬和汽車板塊的股票則出現買入。</p>
<p>盧比對美元的匯率為 89.9 盧比。</p>
<p>MCX 最新合約的黃金價格上漲 1%，每克為 136,274 盧比。</p>
<p>與此同時，白銀價格上漲 5%，每公斤為 235,670 盧比。</p>
<h3><strong>Mangalam Shares Jump After Kedia Stake</strong></h3>
<p>在製藥行業的新聞中，Mangalam Drugs and Organics 的股票受到關注，因為 Kedia Securities 在該公司購買了股份。</p>
<p>NSE 大宗交易數據顯示，由資深投資者 Vijay Kedia 領導的 Kedia Securities 以每股 24.15 盧比購買了 137,794 股 Mangalam Drugs and Organics。根據 BSE 股東結構，截至 2025 年 12 月，管理層持有該公司 50.36% 的股份。</p>
<p>Kedia Securities 是 Vijay Kedia 的投資公司。它投資於在印度證券交易所交易的上市公司和未上市企業，如初創公司。該公司還在房地產領域有投資。</p>
<p>Mangalam Drugs and Organics 擁有近 50 年的經驗，在全球範圍內以生產關鍵的抗瘧疾活性藥物成分（API）而聞名。隨着時間的推移，它擴展到多種產品，受益於強大的規模和運營效率。該公司是亞洲多個產品的領先生產商，也是其中一些產品的全球最大製造商。</p>
<h3><strong>Biocon Tie-Up Boosts Ajanta Pharma Shares</strong></h3>
<p>繼續關注製藥行業的新聞，Ajanta Pharma 的股票受到關注，因為它與 Biocon 簽署了戰略合作伙伴關係，以為 23 個目標國家採購 semaglutide，並在非洲、中東和中亞擁有半獨佔權，這標誌着在這些市場引入新療法的重要一步。</p>
<p>該公司表示，在某些市場中，它一直是使用強大現場團隊的先驅。這一合作將幫助 Ajanta Pharma 增加其 semaglutide 的市場份額。</p>
<p>在印度，該交易將允許 Ajanta 利用其成熟的銷售網絡、廣泛的醫生聯繫和在慢性治療領域的強大存在，銷售某些 Biocon 產品。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.eqimg.com/images/2025/12302025-chart9-equitymaster.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="755" height="352" original-src="https://imageproxy.pbkrs.com/https://www.eqimg.com/images/2025/12302025-chart9-equitymaster.gif"/></p>
<h3><strong>Defence Digital Win Boosts Silver Touch</strong></h3>
<p>繼續關注 IT 行業的新聞，Silver Touch Technologies 的股票受到關注，因為該公司被選為印度海軍在 IPADSV2 計劃下的數字轉型合作伙伴。</p>
<p>這一發展對公司來説是積極的，因為它增強了其國防業務，並預計在未來幾年提供穩定的收入和訂單增長。</p>
<p>作為項目的一部分，Silver Touch 將為印度海軍建立一個數字平台，以提高自動化、效率和安全操作。該平台將幫助管理人員記錄、請假和旅行批准、資產和庫存，並提供實時報告和儀表板。它還將與其他海軍系統連接，確保基於角色的安全訪問，並維護適當的文檔記錄和審計軌跡。</p>
<p>該基於雲的、移動友好的系統將支持關鍵的海軍操作，同時提高長期效率和可擴展性。</p>
<p>Silver Touch Technologies 是一家快速增長的 IT 服務公司，提供技術、諮詢和業務流程解決方案。它利用先進的技術，如人工智能、自動化、雲計算和分析，幫助組織在數字時代實現現代化和成功。</p>
<hr/>
<p><em>更多來自此作者的內容：</em></p>
<p>Nifty 低於 25,950；塔塔鋼鐵和巴賈傑金融是主要跌幅股</p>
<p>Sensex 今天下跌 345 點；Nifty 低於 25,950</p>
<p>Sensex 今天平盤交易；Nifty 低於 26,100</p>

印孚瑟斯技術

<p>印度股市基準指數 Sensex 和 Nifty50 以負面偏向收盤，受到 IT、快速消費品、房地產和製藥行業拋售的影響，儘管公營銀行、金屬和汽車行業有所上漲。Infosys、Eternal 和 HCL Tech 是主要的跌幅股，而塔塔鋼鐵和馬恆達則有所上漲。印度盧比對美元匯率為 89.9。在製藥行業，Mangalam Drugs 被 Kedia Securities 收購了股份，Ajanta Pharma 與 Biocon 合作進行 semaglutide 的分銷。Silver Touch Technologies 被選為印度海軍的數字合作伙伴，增強了其國防業務</p>

<p>Although the benchmark indices opened lower, they traded negatively throughout the session and ultimately closed in red.</p>
<div class="lb-trans"><p>儘管基準指數開盤走低，但在整個交易過程中表現不佳，最終收盤下跌。</p>
</div><p>Indian equity benchmarks, Sensex and Nifty50, ended flat with a negative bias on Tuesday, as strong buying in PSU bank, metal and auto counters was offset by selling in IT, FMCG, realty and pharma shares.</p>
<div class="lb-trans"><p>印度股市基準指數，Sensex 和 Nifty50，週二以負面偏向平盤收盤，儘管公營銀行、金屬和汽車板塊強勁買入，但 IT、快速消費品、房地產和製藥股的拋售抵消了這些買入。</p>
</div><p>At the closing bell, the BSE Sensex closed lower by 20 points.</p>
<div class="lb-trans"><p>在收盤時，BSE Sensex 下跌了 20 點。</p>
</div><p>Meanwhile, the NSE Nifty closed 3 points lower.</p>
<div class="lb-trans"><p>與此同時，NSE Nifty 下跌了 3 點。</p>
</div><p>Tata Steel, M&amp;M, and Bajaj Finserv are among the top gainers today.</p>
<div class="lb-trans"><p>塔塔鋼鐵、馬恆達和巴賈傑金融是今天的主要漲幅股。</p>
</div><p>Infosys, Eternal, HCL Tech, on the other hand, were among the top losers today.</p>
<div class="lb-trans"><p>而 Infosys、Eternal 和 HCL Tech 則是今天的主要跌幅股。</p>
</div><p>The GIFT Nifty was trading at 26,112, higher by 146 points at the time of writing.</p>
<div class="lb-trans"><p>GIFT Nifty 在撰寫時交易於 26,112，上漲 146 點。</p>
</div><p>The BSE MidCap index ended 0.1% lower, and the BSE SmallCap index ended 0.2% lower.</p>
<div class="lb-trans"><p>BSE 中型股指數下跌 0.1%，BSE 小型股指數下跌 0.2%。</p>
</div><p>Sectoral indices are trading mixed today, with stocks in the healthcare sector and realty sector witnessing selling pressure. Meanwhile, shares in the metal and auto sectors witnessed buying.</p>
<div class="lb-trans"><p>行業指數今天表現混合，醫療保健和房地產板塊的股票面臨拋售壓力。與此同時，金屬和汽車板塊的股票則出現買入。</p>
</div><p>The rupee is trading at Rs 89.9 against the US$.</p>
<div class="lb-trans"><p>盧比對美元的匯率為 89.9 盧比。</p>
</div><p>Gold prices for the latest contract on MCX are trading 1% higher at Rs 136,274 per gram.</p>
<div class="lb-trans"><p>MCX 最新合約的黃金價格上漲 1%，每克為 136,274 盧比。</p>
</div><p>Meanwhile, silver prices were trading 5% higher at Rs 235,670 per 1 kg.</p>
<div class="lb-trans"><p>與此同時，白銀價格上漲 5%，每公斤為 235,670 盧比。</p>
</div><h3><strong>Mangalam Shares Jump After Kedia Stake</strong></h3>
<div class="lb-trans"><h3><strong>Mangalam Shares Jump After Kedia Stake</strong></h3>
</div><p>In the news from pharma sector, shares of Mangalam Drugs and Organics came into focus after Kedia Securities bought a stake in the company.</p>
<div class="lb-trans"><p>在製藥行業的新聞中，Mangalam Drugs and Organics 的股票受到關注，因為 Kedia Securities 在該公司購買了股份。</p>
</div><p>NSE bulk deal data showed that Kedia Securities, led by veteran investor Vijay Kedia, bought 1,37,794 shares of Mangalam Drugs and Organics at Rs 24.15 per share. As per the BSE shareholding pattern, promoters held a 50.36% stake in the company as of December 2025.</p>
<div class="lb-trans"><p>NSE 大宗交易數據顯示，由資深投資者 Vijay Kedia 領導的 Kedia Securities 以每股 24.15 盧比購買了 137,794 股 Mangalam Drugs and Organics。根據 BSE 股東結構，截至 2025 年 12 月，管理層持有該公司 50.36% 的股份。</p>
</div><p>Kedia Securities is Vijay Kedia's investment firm. It invests in both listed companies traded on Indian stock exchanges and unlisted businesses such as startups. The firm also has investments in real estate.</p>
<div class="lb-trans"><p>Kedia Securities 是 Vijay Kedia 的投資公司。它投資於在印度證券交易所交易的上市公司和未上市企業，如初創公司。該公司還在房地產領域有投資。</p>
</div><p>Mangalam Drugs and Organics has nearly 50 years of experience and is well known globally for manufacturing key anti-malaria active pharmaceutical ingredients (APIs). Over time, it has expanded into a wide range of products, benefiting from strong scale and operational efficiency. The company is among the leading producers in Asia for several of its products and is the world's largest manufacturer of some of them.</p>
<div class="lb-trans"><p>Mangalam Drugs and Organics 擁有近 50 年的經驗，在全球範圍內以生產關鍵的抗瘧疾活性藥物成分（API）而聞名。隨着時間的推移，它擴展到多種產品，受益於強大的規模和運營效率。該公司是亞洲多個產品的領先生產商，也是其中一些產品的全球最大製造商。</p>
</div><h3><strong>Biocon Tie-Up Boosts Ajanta Pharma Shares</strong></h3>
<div class="lb-trans"><h3><strong>Biocon Tie-Up Boosts Ajanta Pharma Shares</strong></h3>
</div><p>Moving on to the news from pharma sector, shares of Ajanta Pharma came into focus after it entered a strategic partnership with Biocon to source semaglutide for 23 target countries, and semi-exclusive rights in Africa, the Middle East, and Central Asia, marking a meaningful step toward introducing newer therapies in these markets.</p>
<div class="lb-trans"><p>繼續關注製藥行業的新聞，Ajanta Pharma 的股票受到關注，因為它與 Biocon 簽署了戰略合作伙伴關係，以為 23 個目標國家採購 semaglutide，並在非洲、中東和中亞擁有半獨佔權，這標誌着在這些市場引入新療法的重要一步。</p>
</div><p>The company said it has been a pioneer in using a strong field force in some markets. This partnership will help Ajanta Pharma increase its market share for semaglutide.</p>
<div class="lb-trans"><p>該公司表示，在某些市場中，它一直是使用強大現場團隊的先驅。這一合作將幫助 Ajanta Pharma 增加其 semaglutide 的市場份額。</p>
</div><p>In India, the deal will allow Ajanta to sell certain Biocon products by using its well-established sales network, wide doctor connections, and strong presence in chronic therapy segments.</p>
<div class="lb-trans"><p>在印度，該交易將允許 Ajanta 利用其成熟的銷售網絡、廣泛的醫生聯繫和在慢性治療領域的強大存在，銷售某些 Biocon 產品。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.eqimg.com/images/2025/12302025-chart9-equitymaster.gif" alt="" original-src="https://www.eqimg.com/images/2025/12302025-chart9-equitymaster.gif"/></p>
<h3><strong>Defence Digital Win Boosts Silver Touch</strong></h3>
<div class="lb-trans"><h3><strong>Defence Digital Win Boosts Silver Touch</strong></h3>
</div><p>Moving on to the news from IT sector, shares of Silver Touch Technologies came into focus after the company was chosen as the Digital Transformation Partner for the Indian Navy under the IPADSV2 initiative.</p>
<div class="lb-trans"><p>繼續關注 IT 行業的新聞，Silver Touch Technologies 的股票受到關注，因為該公司被選為印度海軍在 IPADSV2 計劃下的數字轉型合作伙伴。</p>
</div><p>This development is positive for the company as it strengthens its defence business and is expected to provide steady revenue and order growth over the coming years.</p>
<div class="lb-trans"><p>這一發展對公司來説是積極的，因為它增強了其國防業務，並預計在未來幾年提供穩定的收入和訂單增長。</p>
</div><p>As part of the project, Silver Touch will build a digital platform for the Indian Navy to improve automation, efficiency, and secure operations. The platform will help manage personnel records, leave and travel approvals, assets and inventory, and provide real-time reports and dashboards. It will also connect with other Navy systems, ensure secure access based on roles, and maintain proper document records and audit trails.</p>
<div class="lb-trans"><p>作為項目的一部分，Silver Touch 將為印度海軍建立一個數字平台，以提高自動化、效率和安全操作。該平台將幫助管理人員記錄、請假和旅行批准、資產和庫存，並提供實時報告和儀表板。它還將與其他海軍系統連接，確保基於角色的安全訪問，並維護適當的文檔記錄和審計軌跡。</p>
</div><p>The cloud-based and mobile-friendly system will support critical Navy operations while improving long-term efficiency and scalability.</p>
<div class="lb-trans"><p>該基於雲的、移動友好的系統將支持關鍵的海軍操作，同時提高長期效率和可擴展性。</p>
</div><p>Silver Touch Technologies is a fast-growing IT services company that provides technology, consulting, and business process solutions. It uses advanced technologies such as AI, automation, cloud, and analytics to help organizations modernize and succeed in the digital age.</p>
<div class="lb-trans"><p>Silver Touch Technologies 是一家快速增長的 IT 服務公司，提供技術、諮詢和業務流程解決方案。它利用先進的技術，如人工智能、自動化、雲計算和分析，幫助組織在數字時代實現現代化和成功。</p>
</div><hr/>
<div class="lb-trans"><hr/>
</div><p><em>More By This Author:</em></p>
<div class="lb-trans"><p><em>更多來自此作者的內容：</em></p>
</div><p>Nifty Below 25,950; Tata Steel &amp; Bajaj Finance Top Losers</p>
<div class="lb-trans"><p>Nifty 低於 25,950；塔塔鋼鐵和巴賈傑金融是主要跌幅股</p>
</div><p>Sensex Today Ends 345 Points Lower; Nifty Below 25,950</p>
<div class="lb-trans"><p>Sensex 今天下跌 345 點；Nifty 低於 25,950</p>
</div><p>Sensex Today Trades Flat; Nifty Below 26,100</p>
<div class="lb-trans"><p>Sensex 今天平盤交易；Nifty 低於 26,100</p>
</div>

Nifty 指數跌破 25,950 點；印孚瑟斯及內部主要虧損者